Acorda Therapeutics
| Type | Public |
|---|---|
| Industry | |
| Founded | 1995 |
| Founder | Ron Cohen |
| Headquarters | 420 Saw Mill River Road, Ardsley, New York, United States |
| Key people | Ron Cohen (CEO) |
| Products | |
| Revenue | |
| Total assets | |
| Total equity | |
Number of employees | 344 (2020) |
| Website | acorda |
Acorda Therapeutics, Inc. is an American biotechnology company based in Pearl River, New York. The company develops therapies that improve neurological function in people with Parkinson's disease, multiple sclerosis and other neurological disorders. Acorda Therapeutics manufactures and markets the drugs Inbrija (levodopa inhalation powder) and Ampyra (dalfampridine) in the United States.